Strong first-half results driven by nearly 10% core organic revenue growth, led by Aerospace & Defense, IGT, and Medical, offsetting automotive weakness. Margins and EPS improved, with continued benefits from the Optimise program and a robust M&A pipeline supporting future growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.